Cryopyrin-associated Periodic Syndromes and the Eye

被引:16
|
作者
Oberg, Thomas J. [1 ]
Vitale, Albert T. [1 ]
Hoffman, Robert O. [1 ]
Bohnsack, John F. [2 ]
Warner, Judith E. [1 ]
机构
[1] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Moran Eye Ctr, Salt Lake City, UT USA
[2] Univ Utah, Dept Pediat, Div Rheumatol & Immunol, Salt Lake City, UT USA
关键词
Apthous ulcers; conjunctivitis; Muckle-Wells; papilledema; uveitis; MANIFESTATIONS;
D O I
10.3109/09273948.2013.765016
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim: To describe the ophthalmologic findings in two patients with Muckle-Wells Syndrome, a phenotype of the Cryopyrin Associated Periodic Syndromes (CAPS) spectrum. There is currently sparse ophthalmic literature regarding the ocular manifestations of CAPS. We hope to increase awareness of this spectrum of diseases and the importance of proper treatment amongst eye care professionals. Methods: Interventional Case Series. Results: Patient 1 experienced resolution of aseptic meningitis, papilledema, and anterior uveitis following treatment with anikinra. Patient 2 experienced resolution of panuveitis following treatment with anikinra. Conclusions: The severe ocular manifestations of the most severe CAPS phenotype, Chronic Infantile Neurological Cutaneous and Articular Syndrome/Neonatal Onset Multisystem Inflammatory Disease Syndrome (CINCA/NOMID) have been previously described. There is increasing evidence that patients may experience similar ocular disease with the milder phenotype of Muckle-Wells Sydnrome. There is also increasing evidence that appropriate therapy can have a profound effect on patient prognosis.
引用
收藏
页码:306 / 309
页数:4
相关论文
共 50 条
  • [1] Cryopyrin-associated periodic syndromes
    Quartier, P.
    Rodrigues, F.
    Georgin-Lavialle, S.
    [J]. REVUE DE MEDECINE INTERNE, 2018, 39 (04): : 287 - 296
  • [2] Cryopyrin-associated periodic syndromes and autoinflammation
    Shinkai, K.
    McCalmont, T. H.
    Leslie, K. S.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2008, 33 (01) : 1 - 9
  • [3] Canakinumab for the cryopyrin-associated periodic syndromes
    Sinisa Savic
    Michael F. McDermott
    [J]. Nature Reviews Rheumatology, 2009, 5 : 529 - 530
  • [4] Canakinumab for the cryopyrin-associated periodic syndromes
    Savic, Sinisa
    McDermott, Michael F.
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2009, 5 (10) : 529 - 530
  • [5] Cryopyrin-associated periodic syndromes: background and therapeutics
    Kubota, Tetsuo
    Koike, Ryuji
    [J]. MODERN RHEUMATOLOGY, 2010, 20 (03) : 213 - 221
  • [6] Cryopyrin-Associated Periodic Syndromes - Recognition and Treatment
    Kuemmerle-Deschner, Jasmin B.
    [J]. AKTUELLE RHEUMATOLOGIE, 2017, 42 (01) : 59 - 65
  • [7] CanakinumabIn Patients with Cryopyrin-Associated Periodic Syndromes
    Monique P. Curran
    [J]. BioDrugs, 2012, 26 (1) : 53 - 59
  • [8] Cryopyrin-Associated Periodic Syndromes Diagnosis and Management
    Miyamae, Takako
    [J]. PEDIATRIC DRUGS, 2012, 14 (02) : 109 - 117
  • [9] CANAKINUMAB FOR THE TREATMENT OF CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES
    Walsh, Garry M.
    [J]. DRUGS OF TODAY, 2009, 45 (10) : 731 - 735
  • [10] Canakinumab In Patients with Cryopyrin-Associated Periodic Syndromes
    Curran, Monique P.
    [J]. BIODRUGS, 2012, 26 (01) : 53 - 59